An intelligent T1-T2 switchable MRI contrast agent for the non-invasive identification of vulnerable atherosclerotic plaques.

Unlike stable atherosclerotic plaques, vulnerable plaques are very likely to cause serious cardio-cerebrovascular diseases. Meanwhile, how to non-invasively identify vulnerable plaques at early stages has been an urgent but challenging problem in clinical practices. Here, we propose a macrophage-targeted and in situ stimuli-triggered T1-T2 switchable magnetic resonance imaging (MRI) nanoprobe for the non-invasive diagnosis of vulnerable plaques. Precisely, single-dispersed iron oxide nanoparticles (IONPs) modified with hyaluronic acid (HA), denoted as IONP-HP, show macrophage targetability and T1 MRI enhancement (r2/r1 = 3.415). Triggered by the low pH environment of macrophage lysosomes, the single-dispersed IONP-HP transforms into a cluster analogue, which exhibits T2 MRI enhancement (r2/r1 = 13.326). Furthermore, an in vivo switch of T1-T2 enhancement modes shows that the vulnerable plaques exhibit strong T1 enhancement after intravenous administration of the nanoprobe, followed by a switch to T2 enhancement after 9 h. In contrast, stable plaques show only slight T1 enhancement but without T2 enhancement. It is therefore imperative that the intelligent and novel nanoplatform proposed in this study achieves a substantial non-invasive diagnosis of vulnerable plaques by means of a facile but effective T1-T2 switchable process, which will significantly contribute to the application of materials science in solving clinical problems.

Synthesis of SPIONs-CNT Based Novel Nanocomposite for Effective Amperometric Sensing of First-Line Antituberculosis Drug Rifampicin.

It is necessary to study the possible interactions among various chemical surfaces and analytes before applying them to biological systems. We report the synthesis of carbon nanotubes-iron oxide (SPIONs-CNT) nanocomposite material by using lecithin stabilized superparamagnetic iron oxide nanoparticles (SPIONs) obtained by facile hydrothermal technique. Various characterizations of the obtained nanocomposite were carried out and electrochemical studies were performed further to study the interaction capabilities of the nanocomposite with anti-TB drug Rifampicin. Obtained results by cyclic voltammetric studies of SPIONs-CNT nanocomposite with limit of detection (LOD) of 1.178 µM showed the enhanced electrochemical sensitivity and selectivity of anti-tuberculosis (anti-TB) drug Rifampicin (RIF).

In-situ synthesis of 3D ultra-small gold augmented graphene hybrid for highly sensitive electrochemical binding capability.

The fascinating properties of graphene can be augmented with other nanomaterials to generate hybrids to design innovative applications. Contrary to the conventional methodologies, we showed a novel yet simple, in-situ, biological approach which allowed for the effective growth of gold nanostructures on graphene surfaces (3D Au NS@GO). The morphology of the obtained hybrid consisted of sheets of graphene, anchoring uniform dispersion of ultra-small gold nanostructures of about 2-8 nm diameter. Surface plasmon resonance at 380 nm confirmed the nano-regimen of the hybrid. Fourier transform infrared spectroscopy indicated the utilization of amine spacers to host gold ions leading to nucleation and growth. The exceptional positive surface potential of 55 mV suggest that the hybrid as an ideal support for electrocatalysis. Ultimately, the hybrid was found to be an efficient receptor material for electrochemical performance towards the binding of uric acid which is an important biomolecule of human metabolism. The designed material enabled the detection of uric acid concentrations as low as 30 nM. This synthesis strategy is highly suitable to design new hybrid materials with interesting morphology and outstanding properties for the identification of clinically relevant biomolecules.